Login / Signup
Toshikatsu Shibata
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 7
Top Topics
Transcription Factor
Drug Discovery
Liver Failure
Emergency Department
Top Venues
Journal of virology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Reina Sasaki-Tanaka
,
Ryota Masuzaki
,
Hiroaki Okamoto
,
Toshikatsu Shibata
,
Mitsuhiko Moriyama
,
Hirofumi Kogure
,
Tatsuo Kanda
Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.
Journal of virology
97 (2) (2023)
Reina Sasaki-Tanaka
,
Ryota Masuzaki
,
Hiroaki Okamoto
,
Toshikatsu Shibata
,
Mitsuhiko Moriyama
,
Hirofumi Kogure
,
Tatsuo Kanda
Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.
Journal of virology
97 (2) (2023)
Reina Sasaki-Tanaka
,
Ryota Masuzaki
,
Hiroaki Okamoto
,
Toshikatsu Shibata
,
Mitsuhiko Moriyama
,
Hirofumi Kogure
,
Tatsuo Kanda
Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.
Journal of virology
97 (2) (2023)
Reina Sasaki-Tanaka
,
Ryota Masuzaki
,
Hiroaki Okamoto
,
Toshikatsu Shibata
,
Mitsuhiko Moriyama
,
Hirofumi Kogure
,
Tatsuo Kanda
Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.
Journal of virology
97 (2) (2023)
Reina Sasaki-Tanaka
,
Ryota Masuzaki
,
Hiroaki Okamoto
,
Toshikatsu Shibata
,
Mitsuhiko Moriyama
,
Hirofumi Kogure
,
Tatsuo Kanda
Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.
Journal of virology
97 (2) (2023)
Reina Sasaki-Tanaka
,
Ryota Masuzaki
,
Hiroaki Okamoto
,
Toshikatsu Shibata
,
Mitsuhiko Moriyama
,
Hirofumi Kogure
,
Tatsuo Kanda
Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.
Journal of virology
(2023)
Reina Sasaki-Tanaka
,
Toshikatsu Shibata
,
Mitsuhiko Moriyama
,
Hiroaki Okamoto
,
Hirofumi Kogure
,
Tatsuo Kanda
Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.
Journal of virology
96 (18) (2022)